Prognostic value of maternal N‐terminal pro‐B‐type natriuretic peptide for prediction of severe maternal adverse outcome in women with pre‐eclampsia
NT-proBNP was a strong predictor of severe maternal adverse outcome and time-to-delivery in women diagnosed with PE, especially in early-onset cases. NT-proBNP may serve as a clinically accessible biomarker for risk stratification and surveillance in women with established PE. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Authors
- Leandra Steinmetz
- Julia Binder (ORCID: https://orcid.org/0000-0002-5725-9270)
- Erkan Kalafat (ORCID: https://orcid.org/0000-0003-0658-138X)
- Tim Dorittke (ORCID: https://orcid.org/0000-0002-9121-3401)
- C. Haberl (ORCID: https://orcid.org/0000-0003-3557-5050)
- Pilar Palmrich (ORCID: https://orcid.org/0000-0003-2449-2575)
- Nawa Schirwani-Hartl
- L. Krepler
Institutions
- Koç University (TR)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Ultrasound in Obstetrics and Gynecology
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1002/uog.70129
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00